Long-term prospective study of steroid withdrawal in kidney and heart transplant recipients

American Journal of Transplantation

Volumn 5, Issue 4 I, 2005, Pages 720-728

  Opelz, Gerhard ^a   Döhler, Bernd ^a   Laux, Gunter ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cataract; Heart transplant; Hyperlipidemia; Kidney transplant; Osteoporosis; Steroid withdrawal

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLESTEROL; CREATININE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; STEROID;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CARDIAC GRAFT REJECTION; CATARACT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORTICOSTEROID INDUCED OSTEOPOROSIS; CREATININE BLOOD LEVEL; DRUG WITHDRAWAL; FEMALE; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STEROID THERAPY; STEROID WITHDRAWAL; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ADULT; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; WITHHOLDING TREATMENT;

EID: 16244380792     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2004.00765.x     Document Type: Article

References (34)

1. Gonin JM. Maintenance immunosuppression: new agents and persistent dilemmas. Adv Renal Repl Ther 2000; 7: 95-116.
2. Citterio F. Steroid side effects and their impact on transplantation outcome. Transplantation 2001; 72 (Suppl): S75-S80.
3. Tarantino A, Montagnino G, Ponticelli C. Corticosteroids in kidney transplant recipients. Safety issues and timing of discontinuation. Drug Saf 1995; 13: 145-156.
4. Lo A, Alloway RR. Strategies to reduce toxicities and improve outcomes in renal transplant recipients. Pharmacotherapy 2002; 22: 316-328.
5. Opelz G. Effect of the maintenance immunosuppressive drug regimen on kidney transplant outcome. Transplantation 1994; 58: 443-446.
6. Kasiske BL, Chakkera HA, Louis TA, Ma JZ. A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol 2000; 11: 1910-1917.
7. Hricik DE, Whalen CC, Lautman J et al. Withdrawal of steroids after renal transplantation - Clinical predictors of outcome. Transplantation 1992; 53: 41-45.
8. Hricik DE, O'Toole MA, Schulak JA, Herson J. Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: a meta-analysis. J Am Soc Nephrol 1993; 4: 1300-1305.
9. Sinclair NR. Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. The Canadian Multicentre Transplant Study Group. CMAJ 1992; 147: 645-657.
10. Collaborative Transplant Study. Newsletter No. 3, 1994. Available at http://www.ctstransplant.org/. Accessed on August 26, 2004.
11. Collaborative Transplant Study. Newsletter No. 4, 1994. Available at http://www.ctstransplant.org/. Accessed on October 25, 2004.
12. Hricik DE, Seliga RM, Fleming-Brooks S, Bartucci MR, Schulak JA. Determinants of long-term allograft function following steroid withdrawal in renal transplant recipients. Clin Transplant 1995; 9: 419-423.
13. Hillebrand G, Schneeberger H, Schleibner S et al. Ten years experience with cyclosporine monotherapy after renal transplantation. Transplant Proc 1993; 25: 513-514.
14. Touchard G, Hauet T, Cogny Van Weydevelt F et al. Maintenance cyclosporine monotherapy after renal transplantation-clinical predictors of long-term outcome. Nephrol Dial Transplant 1997; 12: 1956-1960.
15. Lebranchu Y. Comparison of two corticosteroid regimens in combination with CellCept and cyclosporine A for prevention of acute allograft rejection: 12 month results of a double-blind, randomized, multi-center study. M 55002 Study Group. Transplant Proc 1999; 31: 249-250.
16. Ahsan N, Hricik D, Matas A et al. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil-a prospective randomized study. Steroid Withdrawal Study Group. Transplantation 1999; 68: 1865-1874.
17. Hollander AA, Hene RJ, Hermans J, van Es LA, van der Woude FJ. Late prednisone withdrawal in cyclosporine-treated kidney transplant patients: a randomized study. J Am Soc Nephrol 1997; 8: 294-301.
18. Gulanikar AC, Belitsky P, MacDonald AS, Cohen A, Bitter-Suerman H. Randomized controlled trial of steroids versus no steroids in stable cyclosporine-treated renal graft recipients. Transplant Proc 1991; 23: 990-991.
19. Ratcliffe PJ, Dudley CR, Higgins RM, Firth JD, Smith B, Morris PJ. Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression. Lancet 1996; 348: 643-648.
20. Sivaraman P, Nussbaumer G, Landsberg D. Lack of long-term benefits of steroid withdrawal in renal transplant recipients. Am J Kidney Dis 2001; 37: 1162-1169.
21. Offermann G, Schwarz A, Krause PH. Long-term effects of steroid withdrawal in kidney transplantation. Transpl Int 1993; 6: 290-292.
22. Julian BA, Laskow DA, Dubovsky J, Dubovsky EV, Curtiz JJ, Quarles LD. Rapid toss of vertebral mineral density after renal ransplantation. N Engl J Med 1991; 325: 544-550.
23. Wolpaw T, Deal CL, Fleming-Brooks S, Bartucci MR, Schulak JA, Hricik DE. Factors influencing vertebral bone density after renal transplantation. Transplantation 1994; 58: 1186-1189.
24. Matsunami C, Hilton AF, Dyer JA, Rumbach OW, Hardie IR. Ocular complications in renal transplant patients. Aust N Z J Ophthalmol 1994; 22: 53-57.
25. Ponticelli C. Withdrawal of steroids from a cyclosporine-based regimen: pro. Transplant Proc 1998; 30: 1782-1784.
26. Ojo AO, Hanson JA, Wolfe RA, Leichtman AB, Agodoa LY, Port FK. Long-term survival in renal transplant recipients with graft function. Kidney Int 2000; 57: 307-313.
27. Hricik DE, Bartucci MR, Mayes JT, Schulak JA. The effects of steroid withdrawal on the lipoprotein profiles of cyclosporine-treated kidney and kidney-pancreas transplant recipients. Transplantation 1992; 54: 868-871.
28. Collaborative Transplant Study. Newsletter No. 2, 2003. Available at http://www.ctstransplant.org/. Accessed on August 26, 2004.
29. Olivari MT, Homans DC, Wilson RF, Kubo SH, Ring WS. Coronary artery disease in cardiac transplant patients receiving triple-drug immunosuppressive therapy. Circulation 1989; 80(suppl): III111-III115.
30. Olivari MT, Kubo SH, Braunlin EA, Bolman RM, Ring WS. Five-year experience with triple-drug immunosuppressive therapy in cardiac transplantation. Circulation 1990; 82(suppl): IV276-IV280.
31. Kobashigawa JA, Stevenson LW, Brownfield ED et al. Initial success of steroid weaning late after heart transplantation. J Heart Lung Transplant 1992; 11: 428-430.
32. Miller LW, Wolford T, McBride LR, Peigh P, Pennington DG. Successful withdrawal of corticosteroids in heart transplantation. J Heart Lung Transplant 1992; 11: 431-434.
33. Collaborative Transplant Study. Archive CTS-H-85501-Aug2004, CTS-H-85601-Aug2004, CTS-H-85701-Aug2004, CTS-H85801-Aug2004. Available at http://www.ctstransplant.org/. Accessed on October 25, 2004.
34. Opelz G for the Collaborative Transplant Study. Critical evaluation of the association of acute with chronic graft rejection in kidney and heart transplant recipients. Transplant Proc 1997; 29: 73-76.